MET GENE ALTERATIONS

Clinical trials for MET GENE ALTERATIONS explained in plain language.

Never miss a new study

Get alerted when new MET GENE ALTERATIONS trials appear

Sign up with your email to follow new studies for MET GENE ALTERATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New cancer drug targets genetic weakness in advanced tumors

Disease control Ongoing

This early-stage trial is testing a new oral drug called TPX-0022 (elzovantinib) in adults with advanced or spreading cancers that have specific changes in the MET gene. The study aims to find the safest and most effective dose while checking if the drug helps control tumors in l…

Matched conditions: MET GENE ALTERATIONS

Phase: PHASE1 • Sponsor: Turning Point Therapeutics, Inc. • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC

MET GENE ALTERATIONS

Get alerted when new MET GENE ALTERATIONS trials appear

New cancer drug targets genetic weakness in advanced tumors